Cranial Nerve Neoplasms: Clinical Trials

8 trials for Cranial Nerve Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 2 completed, 1 recruiting, 1 unknown. 8 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Terminated 3, Completed 2, Recruiting 1, Unknown 1, Withdrawn 1
Phase 21Terminated 1

Follow Cranial Nerve Neoplasms: new trials by email Literature Review of Cranial Nerve Neoplasms trials Research Report on Cranial Nerve Neoplasms

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients
Steroids therapy, Placebo - Vestibular Schwannoma, Facial Nerve Paralysis
Phase 3RecruitingBeijing Tiantan Hospital3642025-10-092026-10-26
Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas
REC-2282, Placebo - Neurofibromatosis Type 2
Phase 2 / Phase 3TerminatedRecursion Pharmaceuticals Inc.252022-06-202026-08-17
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Brolucizumab, Aflibercept - Age-Related Macular Degeneration
Phase 3TerminatedNovartis Pharmaceuticals5352018-10-302023-01-30
Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
Temozolomide, ANP Therapy - Optic Nerve Glioma
Phase 3WithdrawnBurzynski Research Institute2011-12-012017-07-26
Stereotactic Radiation in Vestibular Schwannoma
stereotactic radiotherapy, stereotactic radiosurgery - Vestibular Schwannoma
Phase 3UnknownRamathibodi Hospital2002011-10-012011-10-10
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
cyproheptadine hydrochloride, placebo - Cancer
Phase 3TerminatedUniversity of South Florida222010-06-012015-07-02
Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery
methylprednisolone - Facial Palsy
Phase 3CompletedAssistance Publique - Hôpitaux de Paris3132007-03-012012-07-10
Combination Chemotherapy in Treating Children With Progressive Brain Tumors
carboplatin, lomustine, procarbazine hydrochloride - Brain Tumors, Central Nervous System Tumors
Phase 3CompletedChildren's Oncology Group4281997-04-012013-09-09

Narrower conditions

Neuroma, Acoustic (3)  ·  Optic Nerve Glioma (3)  ·  Astrocytoma (2)  ·  Facial Paralysis (2)  ·  Neurofibromatosis 2 (2)  ·  Bell Palsy (1)  ·  Body Weight Changes (1)  ·  Bone Neoplasms (1)  ·  Brain Neoplasms (1)  ·  Cachexia (1)  ·  Central Nervous System Neoplasms (1)  ·  Chondrosarcoma (1)  ·  Choroid Plexus Neoplasms (1)  ·  Familial ependymoma (1)  ·  Fibrosarcoma (1)

Broader conditions

Cranial Nerve Diseases (8)  ·  Neoplasms by Histologic Type (8)  ·  Neoplasms, Germ Cell and Embryonal (8)  ·  Neoplasms, Nerve Tissue (8)  ·  Nervous System Diseases (8)  ·  Neuroectodermal Tumors (8)  ·  Neoplasms (7)  ·  Neoplasms by Site (6)  ·  Nervous System Neoplasms (6)  ·  Peripheral Nervous System Neoplasms (6)  ·  Ear Diseases (5)  ·  Nerve Sheath Neoplasms (5)  ·  Neurilemmoma (5)  ·  Neuroendocrine Tumors (5)

Interventions

Carboplatin (1)  ·  Cyproheptadine (1)  ·  HDAC-42 (1)  ·  Lomustine (1)  ·  Methylprednisolone (1)  ·  Procarbazine (1)  ·  Radiosurgery (1)  ·  Temozolomide (1)  ·  Thioguanine (1)  ·  Vincristine (1)  ·  aflibercept (1)  ·  antineoplaston A10 (1)  ·  antineoplaston AS 2-1 (1)  ·  brolucizumab (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Beijing Tiantan Hospital (1)  ·  Burzynski Research Institute (1)  ·  Children's Oncology Group (1)  ·  Novartis Pharmaceuticals (1)  ·  Ramathibodi Hospital (1)  ·  Recursion Pharmaceuticals Inc. (1)  ·  University of South Florida (1)

Countries

United States (4)  ·  Australia (1)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Puerto Rico (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Jeffrey P. Krischer, PhD (1)  ·  Joann Ater, MD (1)  ·  Putipun Puataweepong, M.D. (1)  ·  Stanislaw R Burzynski, MD, PhD (1)

Results publications

PMID 22665535

NIH funding

U10CA081920 (1)